Novel therapies in rheumatic disease
|
Peripheral stem sell transplantation in SLE.
Immunoapheresis in autoimmune diseases, e.g. RA, SS, SLE etc.
T cell vaccine in SLE.
TCR and HLA-DR4/1 peptide in RA
Bioagent: Infliximab, Enbrel (Entanercept), IL-6 antagonist, CTLA-4, anti-CD20 in SLE 、 RA 、 AS and SS etc .
Low dose CTX puls in SLE.
Artodar ( Diacerin ) in osteoarthritis and RA
Ifosfamide (IFO) puls therapy in SLE.
Hydroxychloroquine (HCQ) in early RA and Undifferentiated arthritis.
Novel drugs such as Cyclosporin and Mycophenolate mofetil,in SLE and SS
Combination therapy in refractory SLE 、 RA 、 SS and AS etc .
|